
Fagron N.V.
ARSUF
Updated: 24/09/2026, 09:07:18
Fagron N.V. is a specialized pharmaceutical compounding firm focused on delivering tailored medicinal solutions. The company caters to a diverse range of clients, including hospitals, pharmacies, clinics, and individual patients. Beyond providing direct services, Fagron N.V. actively drives innovation by developing cutting-edge concepts, delivery methods, and specific formulations for pharmaceutical compounding. Its extensive product line includes essential raw materials, specialized tools and equipment, semi-finished goods, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Furthermore, the company supports professional development through the Fagron Academy, offering comprehensive education and training programs for medical prescribers and pharmacists. With a significant global presence, Fagron N.V. operates across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and headquartered in Nazareth, Belgium, the company underwent a name change in January 2015, rebranding from its former identity, Arseus N.V., to Fagron N.V.
No summaries found.
- Share price
- $27.50
- Market cap
- $2.02B
- Exchange
- OTC
- Currency
- USD
- CEO
- Rafael Padilla
- Employees
- 4,134
- IPO date
- 21/02/2017
- Beta
- 0.386
- Last dividend
- $0.00
- Day range
- $27.50 – $27.50
- 52-week range
- $23.50 – $27.90
- 1-day performance
- 0.00%
- 1-year performance
- 17.02%
- Current drawdown (1Y)
- -1.43%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- BE0003874915
- Created
- 07/12/2025, 02:09:20
- Last update
- 24/09/2026, 09:07:18
Track Fagron N.V. with an AI analyst
See which prediction-market events move ARSUF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Fagron NV (ARSUF) Q1 2026 Sales/Trading Call Transcript
Seeking Alpha • STOCK • 10/04/2026, 09:11:45
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
GlobeNewsWire • STOCK • 09/04/2026, 03:00:00
Fagron NV (ARSUF) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 16/02/2026, 18:37:38